How I manage patients with unexplained cytopenia.

Area of Science:

• Hematology
• Molecular Diagnostics
• Oncology

Background:

• Unexplained cytopenia lacks clear causes via conventional tests.
• It necessitates investigation to detect potential hematologic neoplasms.
• Somatic mutation analysis is emerging as a key diagnostic tool.

Purpose of the Study:

• To highlight the role of somatic mutation analysis in unexplained cytopenia.
• To discuss the identification of myeloid neoplasms (MNs) and clonal cytopenia of undetermined significance (CCUS).
• To present case studies for clinical practice guidance.

Main Methods:

• Review of evidence supporting somatic mutation analysis.
• Discussion of diagnostic and prognostic models.
• Presentation of four clinical case studies.

Main Results:

• Somatic mutation analysis demonstrates high predictive values for MNs.
• Mutation analysis is crucial for diagnosing CCUS, a precursor to MNs.
• Clinical/molecular models aid in personalized surveillance.

Conclusions:

• Somatic mutation analysis is vital for managing unexplained cytopenia.
• CCUS patients require monitoring, with limited therapeutic options.
• This field is under active clinical investigation.